Par 605 (Lamotrigine Extended-Release 300 mg)
Pill with imprint Par 605 is Gray, Round and has been identified as Lamotrigine Extended-Release 300 mg. It is supplied by Par Pharmaceutical Inc..
Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; seizure prevention; anxiety; epilepsy (and more), and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Par 605
Lamotrigine Extended-Release
- Imprint:
- Par 605
- Strength:
- 300 mg
- Color:
- Gray
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Triazine anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Par Pharmaceutical Inc.
- National Drug Code (NDC):
- 49884-0605
More about lamotrigine
- Lamotrigine Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 963 Reviews
- Drug class: triazine anticonvulsants
- FDA Alerts (4)
Consumer resources
- Lamotrigine
- Lamotrigine Chewable Dispersible Tablets
- Lamotrigine Extended-Release Tablets
- Lamotrigine Orally Disintegrating Tablets
- Lamotrigine Tablets
- Lamotrigine (Advanced Reading)
Other brands: Lamictal, Lamictal XR, Lamictal CD, Lamictal ODT, Subvenite
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
